Use of Org 10,172 in the treatment of heparin-induced thrombocytopenia and thrombosis.
作者信息
Kiers L, Grigg L E, Cade J F, Street P R, Chong B H
出版信息
Aust N Z J Med. 1986 Oct;16(5):719. doi: 10.1111/j.1445-5994.1986.tb00027.x.
Abstract
摘要
相似文献
1
Use of Org 10,172 in the treatment of heparin-induced thrombocytopenia and thrombosis.
Aust N Z J Med. 1986 Oct;16(5):719. doi: 10.1111/j.1445-5994.1986.tb00027.x.
2
Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.新型类肝素治疗肝素诱导的血小板减少症伴血栓形成。
Lancet. 1983 Apr 30;1(8331):986-7. doi: 10.1016/s0140-6736(83)92107-4.
3
The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.低分子量类肝素（Org 10172）在肝素依赖型血小板减少症和血栓形成患者体外操作中的应用。
Aust N Z J Med. 1991 Feb;21(1):52-4. doi: 10.1111/j.1445-5994.1991.tb03003.x.
4
Haemofiltration/haemodialysis in patients with heparin-associated thrombocytopenia.
Intensive Care Med. 1991;17(7):437. doi: 10.1007/BF01720689.
5
6
7
Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172).
Thromb Res. 1993 Jul 15;71(2):123-6. doi: 10.1016/0049-3848(93)90178-q.
8
Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid.
Thromb Res. 1991 Apr;62(1-2):23-9. doi: 10.1016/0049-3848(91)90665-j.
9
Treatment of heparin-induced thrombocytopenia.肝素诱导的血小板减少症的治疗。
J Thorac Cardiovasc Surg. 1997 Sep;114(3):517-8. doi: 10.1016/S0022-5223(97)70219-8.
引用本文的文献
1
Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.给予健康老年志愿者低分子量类肝素Org 10172的安全性和药代动力学。
Br J Clin Pharmacol. 1989 Jan;27(1):39-48. doi: 10.1111/j.1365-2125.1989.tb05333.x.
Zotero 插件